Clinical Trial Update: Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial [NA]

View source ↗

Summary

The PACUS trial investigated using ultrasound to enhance paclitaxel uptake in peripheral arterial disease with critical limb ischemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Peripheral Arterial Disease, Angioplasty | NA | Status: COMPLETED